dm199
Generic: rinvecalinase alfa
dm199: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | Phase 2/Phase 3 |
Clinical Trials (1)
DM199 for Pregnancy Complications
Frequently asked questions
Who is developing dm199?
dm199 is being developed by DiaMedica Therapeutics Inc..
How many clinical trials involve dm199?
BioSniper tracks 1 clinical trial involving dm199.
Get deeper analysis on dm199
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis